Prolactin Receptor Signaling Is Essential for Perinatal Brown Adipocyte Function: A Role for Insulin-like Growth Factor-2.: Prolactin and brown adipocytes by Viengchareun, Say et al.
Prolactin Receptor Signaling Is Essential for Perinatal
Brown Adipocyte Function: A Role for Insulin-like
Growth Factor-2.
Say Viengchareun, Nathalie Servel, Bruno Fe`ve, Michael Freemark, Marc
Lombe`s, Nadine Binart
To cite this version:
Say Viengchareun, Nathalie Servel, Bruno Fe`ve, Michael Freemark, Marc Lombe`s, et al.. Pro-
lactin Receptor Signaling Is Essential for Perinatal Brown Adipocyte Function: A Role for
Insulin-like Growth Factor-2.: Prolactin and brown adipocytes. PLoS ONE, Public Library of
Science, 2008, 3 (2), pp.e1535. <10.1371/journal.pone.0001535>. <inserm-00218101>
HAL Id: inserm-00218101
http://www.hal.inserm.fr/inserm-00218101
Submitted on 8 Feb 2008
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destine´e au de´poˆt et a` la diffusion de documents
scientifiques de niveau recherche, publie´s ou non,
e´manant des e´tablissements d’enseignement et de
recherche franc¸ais ou e´trangers, des laboratoires
publics ou prive´s.

   
1 
Prolactin Receptor Signaling is Essential for Perinatal Brown Adipocyte 
Function: a Role for Insulin-like Growth Factor-2 
 
Say Viengchareun1,2, Nathalie Servel3,4, Bruno Fève1,2, Michael Freemark3,4,5, 
Marc Lombès1,2,6, and Nadine Binart3,4,6* 
 
1 Inserm, U693, Le Kremlin-Bicêtre, F-94276, France; 
 
2 Univ Paris-Sud, Faculté de Médecine Paris-Sud, UMR-S693, Le Kremlin-Bicêtre, F-94276, 
France; 
 
3 Inserm, U845, Paris, F-75015, France; 
 
4 Univ Paris-Descartes, Faculté de Médecine René Descartes, Site Necker, UMR-S845, Paris, 
F-75015, France; 
 
5 Division of Pediatric Endocrinology and Diabetes, Duke University Medical Center, 
Durham NC 27710, USA. 
 
6 These authors contributed equally to this work. 
 
 
 
 
 
 
 
 
*Corresponding author:  Dr Nadine Binart 
Tel:        33 1 40 61 53 18 
Fax:       33 1 43 06 04 43 
E-mail address:   binart@necker.fr 
 
Running title:    Prolactin and brown adipocytes 
 
H
AL author m
anuscript    inserm
-00218101, version 1
HAL author manuscript
H
AL author m
anuscript    inserm
-00218101, version 1
PLoS ONE 2008;3(2):e1535
   
2 
ABSTRACT 
Background: The lactogenic hormones prolactin (PRL) and placental lactogens (PL) play 
central roles in reproduction and mammary development. Their actions are mediated via 
binding to PRL receptor (PRLR), highly expressed in brown adipose tissue (BAT), yet their 
impact on adipocyte function and metabolism remains unclear.  
Methodology/Principal findings: PRLR knockout (KO) newborn mice were phenotypically 
characterized in term of thermoregulation and their BAT differentiation assayed for gene 
expression studies. Derived brown preadipocyte cell lines were established to evaluate the 
molecular mechanisms involved in PRL signaling on BAT function. Here, we report that 
newborn mice lacking PRLR have hypotrophic BAT depots that express low levels of 
adipocyte nuclear receptor PPARγ2, its coactivator PGC-1α, uncoupling protein 1 (UCP1) 
and the β3 adrenoceptor, reducing mouse viability during cold challenge. Immortalized PRLR 
KO preadipocytes fail to undergo differentiation into mature adipocytes, a defect reversed by 
reintroduction of PRLR. That the effects of the lactogens in BAT are at least partly mediated 
by Insulin-like Growth Factor-2 (IGF-2) is supported by: i) a striking reduction in BAT IGF-2 
expression in PRLR KO mice and in PRLR-deficient preadipocytes; ii) induction of cellular 
IGF-2 expression by PRL through JAK2/STAT5 pathway activation; and iii) reversal of 
defective differentiation in PRLR KO cells by exogenous IGF-2. 
Conclusions: Our findings demonstrate that the lactogens act in concert with IGF-2 to control 
brown adipocyte differentiation and growth. Given the prominent role of brown adipose tissue 
during the perinatal period, our results identified prolactin receptor signaling as a major player 
and a potential therapeutic target in protecting newborn mammals against hypothermia. 
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INTRODUCTION 
The lactogenic hormones of the placenta (placental lactogens, PL) and pituitary gland 
(prolactin, PRL) regulate a variety of physiological processes involved in gonadal function 
and reproduction, mammary development and lactation, adrenal and pancreatic hormone 
secretion, and intermediary metabolism [1]. In humans and rodents, these actions are mediated 
via binding of lactogens to the prolactin receptor (PRLR), a class I cytokine receptor linked to 
activation of the JAK/STAT signaling pathway [2].  
In postnatal rodents and ungulates, the PRLR and associated STAT5 activity are detected 
in most tissues at various stages of development [2,3]; in the fetus, on the other hand, PRLR 
emerge during mid-late gestation [4–6], when high expression levels are detected in the liver, 
lung, gastrointestinal tract, olfactory epithelium, renal tubules, pancreatic beta cells, and 
brown adipose tissue (BAT). The latter is of particular interest because BAT mediates 
adaptive (nonshivering) thermogenesis [7], the process of heat generation required for 
thermostabilization and survival during delivery and the transition from intrauterine to 
extrauterine life. The key effector of adaptive thermogenesis is uncoupling protein 1 (UCP1), 
whose expression is restricted to BAT mitochondria [8]. UCP1 dissipates the proton gradient 
at the inner mitochondrial membrane to prevent oxidative phosphorylation, generating heat 
rather than ATP. A critical upstream regulator of adaptive thermogenesis is peroxisome 
proliferator gamma co-activator 1 alpha (PGC-1α), which promotes mitochondrial biogenesis 
[9]. 
Recent studies have elucidated the molecular mechanisms controlling BAT development. 
The key transcriptional regulator of adipogenesis in brown, as in white, adipose tissue is 
PPARγ  [10]. Early in the course of adipocyte differentiation, C/EBPβ and δ are expressed 
transiently and contribute to induction of PPARγ and C/EBPα, which is required to maintain 
PPARγ expression. C/EBPα also functions synergistically with PPARγ to promote the 
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expression of genes found in both BAT and WAT [11] as well as PGC-1α and UCP1, which 
are preferentially or exclusively expressed in brown adipocytes. 
The expression of BAT genes is regulated by a number of hormones and growth factors 
including the thyroid hormones, catecholamines, leptin, insulin, and insulin-like growth 
factor-1 (IGF-1). However, cold adaptation can be maintained in the absence of thyroid 
hormones, and deletion of thyroid hormone receptor α and β [12] or of β1, β2 and β3 
adrenergic receptor subtypes [13,14] has no effect on BAT PGC-1α mRNA or UCP1 protein 
levels under non-stressed conditions. Moreover, targeted deletion of the thyroid hormone 
receptors, the insulin receptor, or insulin receptor substrates 1, 2, 3 or 4, which mediate many 
of the metabolic effects of insulin and IGF-1, have no effects on BAT mass in newborn mice 
[12,15–17]. These findings suggest that other hormones or growth factors might contribute to 
BAT growth and function during the fetal or perinatal periods. 
Given their presence in fetal and postnatal plasma and their binding to brown adipocytes in 
vivo and in vitro [4,5,18], we hypothesized that the lactogenic hormones may play a 
physiological role in the regulation of BAT development and thermogenesis during the 
perinatal period. To test that hypothesis, we employed three novel experimental models of 
lactogen action. The PRLR knockout (KO) mouse [19], which cannot respond to either PL (in 
utero) or PRL (perinatal and postnatal periods), was used to assess the effects of lactogen 
resistance in vivo on BAT mass, mitochondrial structure, gene expression, and the adaptation 
to cold. These studies were performed on the day of birth to establish their physiological 
relevance. Immortalized preadipocyte cell lines derived from the interscapular brown adipose 
depots of PRLR KO mice were employed to assess the direct effects of PRL signaling on 
adipocyte differentiation and function in vitro and to determine if reintroduction of PRLR can 
restore brown adipocyte commitment. Finally, the PRL-responsive T37i cell line [18], derived 
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from a BAT hibernoma developed in a transgenic mouse [20], was used to assess the 
molecular mechanisms by which PRLR signaling controls BAT differentiation.  
We discovered that absence of PRLR signaling compromised the growth and 
differentiation of BAT in vivo and in vitro and reduced plasma concentrations and BAT 
expression of insulin-like growth factor-2 (IGF-2), which plays a central role in the control of 
placental and fetal growth [21,22]. We therefore examined the regulation of IGF-2 mRNA 
levels by PRL in isolated brown adipocytes and the effects of IGF-2 on brown adipocyte 
differentiation and growth; we then determined if exogenous IGF-2 could reverse the effects 
of PRLR-deficiency on BAT development in immortalized preadipocyte cell lines. Our 
findings suggest that the lactogens act in concert with IGF-2 to control brown adipocyte 
differentiation and growth. 
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RESULTS 
Brown adipose tissue development is altered in PRLR KO mice 
The demonstration that prolactin receptors (PRLR) are expressed at high levels in brown 
adipocytes of fetal and newborn rodents [5] and are functional in brown adipocytes [18] led us 
to explore the physiological relevance of PRL action in BAT in vivo. To that end, we 
characterized BAT development in newborn PRLR KO mice and their wild type (WT) 
littermates. The body weights of newborn PRLR KO mice were not different from those of 
WT pups; however the absolute interscapular BAT mass, evaluated by its weight and the 
BAT/body weight ratio, was significantly reduced in PRLR KO mice as compared with WT 
littermates (Fig. 1A). These findings suggested that lactogens function as growth factors in 
BAT during fetal development, since the reduction in PRLR KO BAT mass was detected at 
birth.  
To assess further the impact of PRLR deletion on BAT development in vivo, we analyzed 
the histological appearance of brown adipocytes in newborn PRLR KO and WT mice (Fig. 
1B and C). WT brown adipocytes were significantly larger than PRLR KO cells; there was a 
35% decrease in mean cell surface of PRLR KO brown adipocytes (Fig. 1D), corresponding 
to a 50% reduction of cell volume. To determine if the reduction in cell size reflected a 
decrease in cellular lipids, we compared the triglyceride content of PRLR KO BAT depots 
with that of WT depots. Triglyceride content was decreased by 40% in the absence of PRLR 
signaling, highlighting the importance of the lactogens in brown adipocyte function (Fig. 1E). 
However, the activities of citrate synthase (CS) and of glycerol-3 phosphate dehydrogenase 
(G3PDH), one of the enzymatic steps of the tricarboxylic acid cycle also implicated in the 
initiation of lipogenesis, did not differ between WT and KO BAT homogenates 
(Supplemental data Fig. 1S). These observations suggest that the reduction of triglyceride 
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content in PRLR KO BAT results from a defect in adipocyte differentiation rather than a 
defect in lipogenesis per se.  
We next examined the expression of adipogenic markers in order to evaluate the impact of 
PRLR on brown adipocyte differentiation in vivo. PPARγ2 as well as SREBP1 expression in 
BAT were decreased in PRLR KO mice, consistent with a compromised adipocyte 
differentiation (Fig. 1F and G). In addition, there was a striking reduction in PGC-1α mRNA 
levels. Since PGC-1α regulates mitochondrial biogenesis and energy production through 
induction of UCP1 expression and through functional interaction with PPARγ2 and the 
retinoic acid receptor (RXRα), the thermometabolic capacity of PRLR KO mice was 
subsequently evaluated. 
 
Alterations of thermogenesis and BAT mitochondria in PRLR KO animals 
To assess the effects of lactogen resistance (PRLR deletion) on thermogenesis, we 
subjected newborn mice to a cold challenge and calculated their survival rates during the 400-
min period, since alternative methods such as measurement of rectal temperature or indirect 
calorimetry could not be performed on newborn animals. Newborn PRLR KO pups were 
more sensitive to cold exposure than their WT littermates; 50% mortality was observed at 125 
and 200 min, in PRLR KO and WT mice, respectively, and 30% of the WT mice, but none of 
the PRLR KO mice, survived more than 300 min (Fig. 2A).  
The key effector of adaptive thermogenesis and cold adaptation is UCP1. To determine if 
UCP1 expression is altered in PRLR KO animals, we quantified UCP1 expression in 
interscapular BAT. Both UCP1 mRNA and protein levels were significantly reduced in BAT 
of newborn PRLR KO mice (Fig. 2B, 2C), suggesting that UCP1 deficiency accounts for their 
thermogenic defect. Given the prominent role played by the β3 adrenoceptor (β3Adr) in 
mediating catecholamines effects on thermogenesis in rodents [23], β3Adr transcripts were 
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quantified in WT and PRLR KO neonates (Fig. 2D); its significant decrease strongly supports 
the thermogenic defect, and therefore the physiological relevance of PRLR signaling BAT 
function. 
BAT differs from white fat by its high degree of vascularization and mitochondrial density. 
Electron microscopic analysis of BAT demonstrated striking differences in mitochondrial 
morphology of PRLR KO mice compared to WT littermates (Fig. 2E). Smaller, sparse and 
often elongated mitochondria were present in the cytoplasm of PRLR KO brown adipocytes. 
This was associated with reduced fat droplets, in accordance with morphological and 
functional BAT abnormalities. Of note, the number of mitochondrial DNA copies in brown 
adipocytes of PRLR KO mice did not differ from those in WT mice (supplemental data Fig. 
2SA). Accordingly, cytochrome c oxidase (COX) activity, the fourth complex of the 
respiratory chain selected as representative of the mtDNA-dependent mitochondrial activities, 
did not vary between KO and WT BAT (supplemental data Fig. 2SB). Thus, the respiratory 
chain activity of lactogen-resistant brown adipocytes was preserved while their thermogenic 
capacity was clearly impaired. Taken together, these observations strongly suggest that 
lactogen signaling plays a pivotal role in the setting and/or maintenance of thermogenic 
function in BAT. 
 
Differentiation of immortalized PRLR deficient preadipocytes is impaired 
To investigate whether PRLR deficiency limits the ability of brown preadipocytes to 
undergo adipogenic conversion, we isolated cells from the stromal vascular fraction of 
interscapular BAT of PRLR KO and WT newborns. Several brown preadipocyte cell lines 
were established after stable transfection of the P1-TAg expression vector, which contains the 
immortalizing SV40 large T Antigen (TAg) under the control of the proximal promoter of the 
human mineralocorticoid receptor gene. This transgene was previously used to generate the 
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T37i brown adipocyte cell line [20] (Fig. 3A and B). The differentiation capacities of PRLR 
KO and WT cell lines were assessed in order to decipher the molecular events by which 
PRLR signaling contributes to the commitment to the brown adipose phenotype. Fig. 3C 
presents results obtained with representative clones of WT and PRLR KO preadipocytes. At 
post confluence (day 0) both cell lines exhibited fibroblast-like morphology and expressed the 
SV40 TAg, as demonstrated by its nuclear immunodetection (inset). After 6 days of exposure 
to insulin and T3, the WT preadipocytes differentiated and accumulated triglycerides within 
multilocular fat droplets (Fig. 3C, upper panel). In contrast, PRLR KO preadipocytes failed to 
accumulate cytoplasmic lipid droplets (Fig. 3C, middle panel), suggesting that PRLR 
signaling plays a crucial role in brown adipocyte differentiation. Similar results were obtained 
in all other independent cell lines derived from PRLR KO animals (data not shown).  
To assess further the role of PRLR signaling in response to PRL and PL which are present 
in the fetal calf serum, we stably transfected a murine PRLR expression vector into PRLR KO 
preadipocytes (KO+PRLR) and examined the adipogenic activation cascade. After 6 days 
exposure to the differentiation mixture (insulin + T3), PRLR-rescued cells accumulated 
triglycerides and acquired the morphologic appearance of mature brown adipocytes (Fig. 3C, 
lower panel). RT-PCR analysis performed on WT, PRLR KO and PRLR-rescued cell lines 
confirmed that expression of PRLR correlated with that of PPARγ2, a marker of adipocyte 
differentiation, and of UCP1, a marker of brown adipocyte lineage (Fig. 3D). These findings 
establish conclusively a direct role for lactogen signaling in brown adipocyte differentiation.   
 
Identification of IGF-2 as a target of lactogen signaling in BAT 
BAT differentiation is under the control of many hormones and growth factors including 
insulin and IGF-1. Since IGF-2 has been previously shown to mediate PRL signaling during 
mammary gland morphogenesis [24], we hypothesized that this growth factor might be a 
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mediator of PRL-induced adipocyte differentiation. To test this possibility, we first compared 
the levels of IGF-2 mRNA in BAT of newborn PRLR KO mice with those in WT mice. IGF-
2 transcript levels were 70% lower in BAT of PRLR KO mice than in BAT of WT littermates 
(Fig. 4A), indicating that endogenous IGF-2 gene expression might be under the direct control 
of PRLR signaling in brown adipocytes. There was also a 35% reduction in IGF-2 plasma 
levels in PRLR KO neonates (Fig. 4B), providing further evidence that lactogens regulate 
IGF-2 production during the fetal and perinatal periods. 
Support for a role for PRLR signaling in IGF-2 production was provided by studies of the 
effects of PRL on IGF-2 expression in brown adipocytes in vitro. We first examined the 
changes in IGF-2 mRNA levels during insulin/T3-induced differentiation of immortalized 
brown preadipocytes from newborn WT mice. As shown in Fig. 4C, IGF-2 mRNA levels 
were significantly higher in differentiated than in undifferentiated cells; thus brown adipocyte 
differentiation is accompanied by a sharp induction of IGF-2 expression. We next compared 
the levels of IGF-2 mRNA in immortalized PRLR KO cells and KO+PRLR cells with those 
in WT cells. IGF-2 mRNA levels were 75% lower in insulin/T3-treated PRLR-KO cells than 
in WT cells on day 6. IGF-2 expression was restored by re-introduction of PRLR into PRLR 
KO cells. Finally, we showed that a 3 h-PRL exposure provokes a 2-fold increase in the levels 
of IGF-2 mRNA in T37i brown adipocytes (Fig. 4D). Collectively, these findings establish a 
critical role for lactogen signaling in brown adipocyte IGF-2 expression. 
The mechanisms by which lactogens regulate IGF-2 are currently unknown. Since PRL is 
known to mediate most of its effects through activation of the JAK2/STAT5 pathway, we 
determined if the specific JAK2 inhibitor AG490 could blunt the effect of PRL on IGF-2 
expression in T37i cells. As illustrated in Fig. 4D, we showed that the induction by PRL of 
IGF-2 mRNA levels was abolished in the presence of AG490. We next showed that PRL 
treatment of differentiated T37i cells induced phosphorylation of STAT5 within 15 min (Fig. 
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4E). Since the IGF-2 gene promoter contains multiple consensus STAT binding sites, we 
performed electromobility shift assays with nuclear extracts of untreated or PRL-treated T37i 
cells and the STAT response element located -3184 bp upstream of the transcription initiation 
start site of IFG-2 gene (exon 1) (Fig. 4F). Specific oligonucleotide-protein complexes were 
detected in PRL-stimulated extracts, a finding compatible with a model in which PRL 
regulates IGF-2 transcription through STAT5 activation.  
 
IGF-2 induces brown adipocyte proliferation and differentiation 
 Given the effects of lactogen signaling on IGF-2 expression in BAT, we addressed the role 
of IGF-2 in preadipocyte proliferation and adipogenesis. To test whether IGF-2 was able to 
stimulate mitogenesis of brown adipocytes, we exposed postconfluent (day 2) and 
differentiated (day 7) T37i cells to 20 nM IGF-2 or insulin (which served as a positive 
control) and measured 3H-thymidine incorporation (Fig. 5A). Treatment of proliferating cells 
with nanomolar concentrations of IGF-2 induced a 3-fold increase in 3H-thymidine 
incorporation. IGF-2 stimulated a 2-fold increase in 3H-thymidine incorporation even in 
differentiated cells, which as expected had lower basal rates of DNA synthesis than 
undifferentiated cells. The potency of IGF-2 in these respects was comparable to that of 
insulin. Longer exposure to IGF-2 stimulation induced morphological changes and the 
appearance of intracytoplasmic lipid droplets in T37i cells, demonstrating a major impact of 
IGF-2 on brown adipocyte differentiation (Fig. 5B). Quantification of Oil Red O staining and 
measurement of PPARγ2 mRNA levels established that IGF-2 was as or more potent than 
insulin in induction of brown adipocyte differentiation (Fig. 5B).  
The mechanisms by which IGF-2 stimulates adipogenesis are currently unknown, but the 
receptors that mediate most IGF-2 effects in the fetus and placenta, namely insulin receptor 
form A (IR-A) and IGF-1 receptor (IGF-1R) [25] were expressed in brown adipocytes 
H
AL author m
anuscript    inserm
-00218101, version 1
H
AL author m
anuscript    inserm
-00218101, version 1
   
12 
(Supplemental data Fig. 3S). In addition, IGF-2 receptor (IGF-2R), which mediates IGF-2 
turnover by endocytosis, was also detected in brown adipocytes. Since IGF-2 and insulin have 
been shown to differentially regulate gene expression through IR-A [26], the respective 
contributions of insulin and IGF-2 signaling in brown adipocyte proliferation and 
differentiation remain to be established. 
 
IGF-2 can partially reverse the effect of PRLR-deletion on BAT differentiation 
 Given the adipogenic effects of IGF-2 in T37i cells and the induction by PRL of  
IGF-2 expression, we next determined if incubation with exogenous IGF-2 could reverse the 
defect in brown adipocyte differentiation observed in PRLR KO cells. As shown in Fig. 5C, 
IGF-2 promoted partial differentiation of PRLR KO cells, with appearance of foci of mature 
adipocytes. This finding suggests that IGF-2 can bypass the absence of PRLR and exert its 
actions downstream of PRL signaling. Our findings provide strong evidence that IGF-2 
constitutes one of the major PRL targets in brown adipocytes and are compatible with an 
autocrine regulatory loop in which PRL stimulates endogenous IGF-2 production, which in 
turn facilitates activation of adipogenesis in BAT. 
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DISCUSSION 
The lactogens play important roles in carbohydrate metabolism through effects on 
pancreatic beta cell mass and insulin production [27,28] and peripheral insulin sensitivity [29], 
however their roles in energy homeostasis and lipid metabolism are poorly understood [30]. In 
this study, we demonstrate that lactogen signaling is essential for brown adipocyte growth and 
differentiation, thermogenic gene expression, and the adaptation to cold stress. Newborn 
PRLR KO mice have impaired BAT development as illustrated by sharp decreases in BAT 
weight, adipocyte size, and triglyceride content. The impaired development of BAT is 
underscored by a significant decrease in the expression of UCP1, which could be the 
consequence of altered BAT development, as illustrated by the decrease of PPARγ2 and its 
coactivator PGC-1α. It is well established that PPARγ2 is important for the development of 
BAT since mouse models with adipose-specific PPARγ ablation have reduced or absent 
interscapular BAT [31]. Maladaptive responses to cold have been described in mouse models 
with deletions in PGC-1α   [32] and PPARγ [33].  Moreover, the cold sensitivity of PRLR KO 
neonates is also amplified by the reduced expression of β3Adr, a key effector for UCP1 
expression in rodents [23]. Importantly, we observed a major thermoregulatory defect in 
PRLR KO animals at birth, highlighting the physiological importance of PRL signaling in 
adaptive thermoregulatory responses to cold challenge. Previous studies [34] demonstrating a 
thermogenic effect of PRL in sheep are consistent with our findings. It is currently unclear if 
the thermogenic effect of PRL is exerted throughout development, but the body temperature 
of PRLR KO adult mice was reported significantly lower than in WT animals [35]. 
To assess the impact of lactogen action on brown adipocyte physiology, we examined the 
effects of PRLR deletion on brown adipocyte differentiation in vitro. We showed that 
immortalized brown preadipocytes from WT newborn mice differentiated during exposure to 
insulin and T3 and expressed the adipogenic genes PPARγ2 and UCP1. In striking contrast, 
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PRLR-deficient cells failed to differentiate or to express these adipogenic genes despite long-
term treatment with insulin and T3. This finding indicates that PRLR signaling, like 
insulin/IGF-1 signaling, is required for BAT differentiation. Whether or not lactogen action is 
also required for white adipose tissue differentiation is unclear, but PRL induces PPARγ and 
C/EBPβ mRNA levels in NIH 3T3 cells [36] and adult female PRLR KO mice have 
reductions in abdominal fat mass and decrease in adipocyte numbers [37–39].  Τhis illustrates 
that beyond the role of PRLR signaling in adaptive thermogenesis at birth, this pathway may 
also affect later, white adipose tissue development and metabolism. 
A novel finding of our study is the first demonstration that IGF-2 serves as a downstream 
target of lactogen action in the differentiation of brown adipocytes. We showed that PRLR 
deletion is accompanied by reductions in BAT IGF-2 mRNA levels in vivo and in vitro and 
that PRL stimulates IGF-2 expression in brown adipocytes. The latter effect appears to be 
mediated through JAK/STAT induction of IGF-2 transcription. We then showed that IGF-2 
stimulates the proliferation and differentiation of brown adipocytes and reverses partially the 
defects in brown adipogenesis observed in PRLR-deficient cells. Even though IGF-2 only 
represents one of the molecular PRL targets involved in BAT growth and differentiation, this 
illustrates that it can bypass the absence of PRLR and thereby acts downstream of lactogen 
signaling. The molecular mechanisms by which IGF-2 exerts its actions are not entirely clear, 
but the receptors that mediate its effects on placental and fetal growth, namely, the IGF-1R 
and IR-A, are expressed in the BAT of newborn mice.  
It is of considerable interest that plasma IGF-2 levels were reduced significantly in PRLR 
KO mice on the day of birth. This new observation suggests that lactogenic hormones that 
circulate in the fetus in late gestation (in rodents, PL, in humans, PL, PRL, and growth 
hormone) may also induce IGF-2 expression in tissues other than BAT; in theory, these could 
include the placenta and fetal liver, adrenal, pancreatic beta cells, and mesenchymal tissues, 
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all of which express PRLR as well as IGF-2 [4–6,21]. In rodents, the expression of IGF-2 
ceases a few weeks after birth and postnatal murine growth is IGF-2 independent [21]. In 
contrast, IGF-2 levels are maintained throughout development in humans, and IGF-2 levels 
are variably decreased in children with growth hormone deficiency [40]. 
The reductions in BAT IGF-2 expression and plasma IGF-2 concentrations in PRLR KO 
neonates suggest a model whereby lactogen action in BAT may be mediated in part through 
systemic and/or local IGF-2 production. This model is illustrated in Fig. 6. Prolactin and/or 
PL bind to the PRLR of the brown adipocyte leading to the activation of various signaling 
pathways including the MAP kinase (MAPK), phosphatidyl-inositol 3-kinase (PI-3K), and 
JAK2/STAT5 pathways and potentiation of IRS signaling [18]. This results in transcriptional 
activation of genes including IGF-2, which is secreted and exerts 
autocrine/paracrine/endocrine effects by binding to IR-A and IGF-1R. Lactogen signaling 
thereby promotes cell proliferation, brown adipocyte differentiation and UCP1-mediated 
thermogenesis. 
The finding that IGF-2 reverses only partially the effects of PRLR deletion suggests that 
PRL target genes other than IGF-2 might be of major pathophysiological importance. 
Interestingly, direct comparison between the predictive anti-adipogenic genes [41] and the 
putative PRL target genes identified by microarrays [24] reveals a strikingly homologous list 
of candidates. They include genes related to cell adhesion and extracellular matrix [42], Wnt 
signaling pathway [43], cell growth and maintenance which have been already described to 
play roles in adipocyte biology. Additional experiments must be undertaken to ascertain the 
involvement of the gene candidates linking PRLR signaling and adipocyte differentiation. 
In summary, our findings reveal the critical role played by PRLR signaling in brown 
adipocyte growth and differentiation, thermogenesis, and the response to cold stress. The 
mediation of lactogen action by induction of IGF-2 expression provides a novel mechanism 
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subserving perinatal adaptation and energy homeostasis. Given the importance of intrauterine 
programming and BAT in energy balance, our findings implicate new roles for the lactogens 
in the interface between fetal and perinatal development and metabolic disease.   H
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 MATERIALS AND METHODS 
 
PRLR KO mice. All experimental designs and procedures are in agreement with the 
guidelines of the animal ethics committee of the Ministère de l’Agriculture (France). WT, and 
PRLR KO mice on a pure 129 genetic background were generated by heterozygous 
crossbreeding [19]. PCR analysis of tail DNA determined the genotypes of the offspring as 
described previously [44].  
Histological analyses. BAT was isolated from the interscapular space of newborn WT 
and PRLR KO mice, fixed in 4% paraformaldehyde, dehydrated and embedded in paraffin. 
Sections (4 µm) were deparaffinized in xylene, rehydrated and stained with hematoxylin 
eosin. The adipocyte surfaces were analyzed using a Lucia software on 200 sections per 
genotype. Data are mean ± SE, for 4 mice per genotype.  
Cell extracts, biochemical determinations, and enzyme assays. BAT was 
homogenized in 25 mM Tris, pH 7.5, 1 mM EDTA. A fraction of the homogenate was stored 
at -80 °C. The remaining fraction was centrifuged at 10,000 x g for 10 min at 4 °C, and the 
supernatant was kept at -80 °C until use. Aliquots of homogenates and supernatants were used 
to determine protein content. Triglyceride content was determined on homogenates with 
PAP150 triglyceride kit (Biomérieux, Marcy L'Etoile, France).  
Electron-microscopic analyses. BAT were washed with PBS and fixed for 4 h with 2% 
glutaraldehyde (Merck) - 2% paraformaldehyde (Sigma) in 0.1 M phosphate buffer, pH 7.4 
(Merck) at room temperature. Tissues were rinsed in PBS, postfixed with 2% osmium 
tetroxyde (Uptima, Montlucon, France) for 30 min, dehydrated in graded ethanol, and 
embedded in Durcupan (Fluka, St Quentin, France). Ultrathin sections were realized and 
examined with a JEOL 1010 electron microscope.  
RT-PCR. Total RNA was extracted from cells with TRIZOL reagent (InVitrogen, Cergy 
Pontoise, France) according to the manufacturer’s recommendations and RNA were thereafter 
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processed for RT-PCR, as previously described [45]. Table I indicates primer sequences of 
genes analyzed by RT-PCR or by quantitative real time PCR. 
Quantitative real time PCR. Specific gene expression was quantified by real time PCR, 
using an ABI 7300 Sequence Detector (Applied Biosystems, Foster City, CA). Briefly, 1 µg of 
total RNA was treated using DNase I Amplification Grade procedure (Invitrogen). RNA was 
thereafter reverse-transcribed with 200 units of reverse transcriptase using the SuperscriptTM II 
kit (InVitrogen), then samples were diluted 10-fold and 1/20th of the reverse transcription 
reaction was used for PCR using the qPCRTM Mastermix Plus for SybrTM Green I (Eurogentec, 
Seraing, Belgium), as previously described [45]. Controls without reverse transcriptase and 
without template were included to verify that fluorescence was not overestimated by residual 
genomic DNA amplification or from primer dimer formation. Moreover RT-PCR products 
were analyzed in a post-amplification fusion curve to ensure that a single amplicon was 
obtained. Quantification was performed by the standard curve method. Standard curves were 
generated by serial dilutions of a linearized plasmid containing the specific amplicon, spanning 
six orders of magnitude, yielding a correlation coefficient of at least 0.98 in all experiments. 
For all experiments, PCR efficiency was close to 1, indicating a doubling of DNA at each PCR 
cycle, as expected. Ribosomal 18S RNA was used to normalize for RNA quality, quantity and 
RT-efficiency. Relative expression within a given sample was calculated as the ratio (attomol 
of specific gene/fmol of 18S). Results are expressed as mean ± SE and represent the relative 
expression compared to that obtained with control animals or cells. 
Kaplan-Meier. All experiments and animal care were performed in accordance with the 
animal facility of the Faculty of Medicine Necker. Cold tolerance was accessed by housing 
newborn mice at 4°C. When no sign of tactile stimulation was observed, the mice were 
sacrificed. We found that mice up to 6 h were considered without using death as an end-point. 
H
AL author m
anuscript    inserm
-00218101, version 1
H
AL author m
anuscript    inserm
-00218101, version 1
   
19 
The survival rate was calculated and expressed according to Kaplan-Meier 
representation. 
Western blot analyses. Total protein extracts were prepared from BAT isolated from 
WT and PRLR KO mice. Tissues were washed twice with ice-cold PBS and lysed as 
described in [18], then 2 µg of total protein were directly submitted to SDS-PAGE. After 
protein blotting on a nitrocellulose membrane (Biorad, Marnes-La Coquette, France), blots 
were incubated for 1 h at room temperature in 5% milk-Tris buffer saline/ 0.1% Tween before 
incubation with the goat anti-UCP1 (1:3000) (a gift from Pr. D. Ricquier) overnight at 4°C. 
After extensive washes, membranes were incubated with a goat peroxidase-conjugated second 
antibody (1:2000) for 1 h at room temperature and proteins were visualized as mentioned 
above. After milk saturation, blots were reincubated overnight with rabbit anti-ERK1/2 
(1:1000) (Upstate Biotechnology, Charlottesville, VA) then incubated with a rabbit 
peroxidase-conjugated second antibody (1:10000) for 1 h at room temperature and proteins 
were visualized by use of the ECL+ detection kit.  
IGF-2 measurement. IGF-2 was measured by RIA [46] after extraction of IGF binding 
proteins on a BioGel P-10 (Bio-Rad, Hercules, CA) column equilibrated in 1 M acetic acid. 
The method has been validated for complete separation of IGFBPs from IGFs in serum and 
other biological fluids. The IGF-2 assay uses recombinant human IGF-2 as standard and 
tracer and a mouse monoclonal antibody. The intra- and inter-assay coefficients of variation 
are less than 10%. The sensitivity of the IGF-2 assay is 50 pg/ml. 
Immortalization of WT and PRLR KO preadipocytes. Brown adipocytes and their 
precursor cells were isolated from newborn mice by collagenase (1 mg/ml) digestion (Serva, 
Heidelberg, Germany) for 15 min at 37°C as described in [47]. Preadipocytes were thereafter 
immortalized by stable transfection with 2.5 µg of HA-TAg SV40 plasmid and 0.5 μg of 
pEGFP plasmid (Clontech, Palo Alto, CA) using Lipofectamin Reagent Plus (InVitrogen). 
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The plasmid HA-TAg SV40, encoded the Large T Antigen of the simian virus 40 placed 
under the control of the proximal promoter of the human mineralocorticoid receptor gene. 
This plasmid was originally used as a transgene and allowed to generate the T37i cell line 
derived from a hibernoma of a transgenic mouse [20]. The pEGFP plasmid encoded for the 
enhanced green fluorescent protein and for the NeoR gene. Transfected cells were selected in 
the presence of 400 μg/ml of geneticin (G418, InVitrogen). Selective medium was changed 3 
times a week for 2 weeks. Foci of cells were isolated using cloning rings and expanded when 
possible. PRLR-rescued brown adipocytes were obtained by transfecting PRLR KO cells with 
a  2.2 kb mouse PRLR cDNA previously subcloned into pcDNA 3.1 hygro expression vector 
(InVitrogen) after selection with 200 µg/ml hygromycin. 
Cell culture. All established cell lines but also T37i brown adipose cell line were 
cultured in a complete medium composed of DMEM/HAM's F12, 10% fetal calf serum, 2 
mM glutamine, 100 IU/ml penicillin, 100 µg/ml streptomycin, and 20 mM HEPES and were 
grown at 37°C in a humidified atmosphere with 5% CO2. Differentiation into mature brown 
adipocytes was achieved by incubating subconfluent cells with complete medium 
supplemented with 2 nM triiodothyronine (Sigma, Saint Quentin Fallavier, France) and 20 
nM insulin for 7 days. All products were purchased from InVitrogen except when stated. 
Before each hormonal treatment, human PRL was produced by recombinant technology then 
purified as described previously [48]. Human IGF-2 was purchased from Calbiochem (La 
Jolla, CA).  
Immunodetection of the SV40 large T antigen. Immunodetection was performed 
using a monoclonal anti-SV40 large T Antigen antibody (Ab-2; Calbiochem). Cells were 
seeded on glass slides and fixed with 100% ethanol, rinsed with PBS, and incubated with a 
1:100 dilution of the primary antibody for 45 min at 37°C. After washing, cells were 
incubated for 30 min at 37°C with a 1:150 dilution of the biotinylated goat anti-mouse 
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antibody (Tebu, Le Perray en Yvelines, France) followed with an incubation for 30 min at 
37°C with a 1:100 dilution of CY3-streptavidine (Jackson ImmunoResearch Laboratories, 
West Grove, PA).  
Studies of the activation of STAT5 signaling pathway. Differentiated T37i cells, 
starved for 18 h in minimum medium, were stimulated with 100 ng/ml PRL, during 0, 5 and 
15 min; cells were washed twice with ice-cold PBS and lysed as previously described [18]. 
Five hundred μg of total protein were immunoprecipitated overnight at 4°C with protein A 
sepharose (Amersham) and the rabbit polyclonal anti-STAT5 (C17 Santa Cruz), reduced in 
Laemmli buffer and a 8% acrylamide SDS-PAGE was performed. Electrotransferred proteins 
were incubated with monoclonal anti-phosphotyrosine (1/5000 clone 4G10 Upstate 
Biotechnology) followed by incubation with the secondary antibody: anti-mouse IgG 
peroxydase-linked (GE Healthcare), detected with ECL western blotting detection reagent 
(GE Healthcare) and exposed to a film (Konica X-ray film AX, Roissy, France). Blots were 
stripped by a 30 min-incubation at 50°C in 62.5 mM Tris-HCl pH 6.8, 2% SDS, 100 mM 2-
mercaptoethanol, washed with TBS/0.1% Tween 20 and were incubated with anti-STAT5 and 
anti-rabbit IgG peroxydase-linked (GE Healthcare) as secondary antibody.  
EMSA. Cells were washed with cold PBS and homogenized in 20 mM HEPES, pH 7.9, 
1.5 mM MgCl2, 600 mM NaCl, 0.2 mM EDTA, 0.5 mM phenylmethylsulfonyl fluoride, 25% 
glycerol and 0.1% protease and phosphatase inhibitor cocktail (Sigma) by 20 strokes in a 
glass-glass Potter apparatus at 4°C. The homogenates were centrifuged at 20,000 xg for 30 
min at 4°C, and the supernatant was used as whole cell extracts. Gel mobility shift assays 
were performed essentially as described in [49]. Purified oligonucleotides were annealed and 
labeled with [32P]-dCTP (GE Healthcare) using the Klenow fragment of DNA polymerase 
(Life Technologies, Inc., Paisley, UK) to a specific activity of approximately 108 cpm/µg of 
DNA. Unlabeled oligonucleotides were used as competitors. Oligonucleotide sequences were 
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as follows: IGF-2-forward: 5'-GCCAGATGTTCTTGGAATGGGACA-3' ; IGF-2-rev : 5'-
GTGTCCCATTCCAAGAACATCTGG-3'. Protein-DNA complexes were separated from 
free DNA by electrophoresis on nondenaturing 4.5% polyacrylamide gel in 0.25X Tris-
borate-EDTA buffer at 200 V for 1 h. Gels were dried and exposed to x-ray film at -80° C. 
Proliferation assays. T37i cells were cultured in 24-well plates. Post-confluent cells 
(d2) and differentiated cells (d7) were rinsed and grown for 12 h in a serum-free medium 
(DMEM/HAM’s F12 containing 2 nM T3), then maintained at 37 °C in the same medium for 
an additional 8 h period, in the absence or presence of 20 nM IGF-2 or insulin, and 1µCi/well 
of [3H]-Thymidine (GE Healthcare) was added during the last 2 h. Cells were washed twice 
with ice-cold PBS and lysed in 1% SDS. DNA was precipitated by 10% trichloroacetic acid. 
The resulting trichloroacetic acid-insoluble pellet was washed two times with 5% 
trichloroacetic acid and collected on Whatman GF/C filters. [3H]-Thymidine incorporation 
into DNA was measured by scintillation counting.  
Statistical analyses. All data were prepared for analysis with standard spread sheet 
software (Microsoft Excel). Data are expressed as the mean ± SE. Statistical analysis was 
performed using Student’s t test to determine significant differences among groups and were 
performed using the computer software Prism 4 (GraphPad Software, San Diego, CA). We 
performed ANOVA, if statistical significance (P values *<0.05, **<0.01 and ***<0.001) was 
achieved and post-test analysis to account for multiple comparisons was done.  
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FIGURE LEGENDS 
 
Figure 1: Lack of PRLR impaired brown adipose tissue development in newborns 
A) Body weight (BW), BAT weight and BAT/BW ratio were determined in newborn wild 
type (WT) and PRLR (KO) mice. The BAT weight and BAT/BW ratio were significantly 
lower in PRLR KO mice (n=16) than in WT animals (n=15) (*p<0.05). Results represent 
mean ± SE. 
B, C and D) Decreased brown adipocyte size in BAT of PRLR KO (C) compared to WT 
mice (B). BAT of newborn animals were collected, fixed and stained with hematoxylin and 
eosin. Representative images are presented (objective x 60). Adipocyte cell surface was 
calculated using the Lucia software and a significant decreased was detected in PRLR KO 
mice (n=5) vs controls (n=5) (***p<0.001, n= 200 cells /group). 
E) Intracellular triglyceride content of BAT was significantly reduced in PRLR KO mice 
(**p<0.01). 
F, G and H) Drastic decrease of PPARγ2, SREBP1 and PGC-1α mRNA expression in BAT 
of PRLR KO mice compared to control littermates. BAT of WT and PRLR KO newborn mice 
were collected, total RNA extracted and processed for quantitative real time PCR analysis of 
gene expression as described in the Materials and Methods section. Relative expression 
within a given sample was calculated as the ratio (attomol of specific gene/fmol of 18S). 
Results are presented as mean ± SE of 15-16 animals. * p<0.05 and ** p <0.01. 
 
Figure 2: Alteration of thermogenesis in PRLR KO mice 
A) PRLR KO newborn mice are more sensitive to cold exposure. Newborn animals were 
maintained in a 4°C environment and their survival was measured as a function of time (min). 
Kaplan-Meier representation of survival rate of KO (n=6) and WT (n=8) mice reveals a 
statistical difference (p<0.022). 
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B) UCP1 mRNA expression in BAT of PRLR KO mice was significantly reduced compared 
to WT littermates. Quantitative real time PCR analysis of UCP1 mRNA expression was 
performed as described above. Results, expressed as attomol of UCP1/fmol of 18S, represent 
mean ± SE of 15-16 animals (*** p <0.001). 
C) Western blot analysis of UCP1 expression in BAT of PRLR KO compared to WT mice. 
BAT of newborn animals were collected, lysed and 2 μg of proteins from homogenates were 
processed for immunoblotting with specific antibodies against UCP1 and ERK1/2. 
Quantification of UCP1 signal ratio was measured by densitometry using the Quantity One 
software (Biorad) and a significant decreased was detected in PRLR KO mice vs controls 
(***p<0.001, n= 6 per group). 
D) β3 adrenoceptor expression in BAT of PRLR KO mice was significantly reduced 
compared to WT littermates. Results, expressed as attomol of β3AdR /fmol of 18S, represent 
mean ± SE of 15-16 animals (*p <0.05). 
E) Representative transmission electron-microscopic images of brown adipocytes of 
interscapular BAT from a WT newborn mouse and PRLR KO littermate. WT brown 
adipocytes exhibited intracytoplasmic lipid vacuoles and numerous mitochondria. Note that 
the mitochondria are extremely dense, compacted and characterized by their round shape and 
packed cristae encompassing the entire organelles (see arrow). Virtually, no cytoplasmic 
compartment is visible. In contrast, mitochondria in PRLR KO brown adipocytes are smaller, 
less packed and presented with elongated and fusiform features. The amount of cristae seems 
to be reduced (inset). Magnification X 15,000. 
 
Figure 3: PRLR is crucial for brown adipocyte differentiation 
A) Schematic representation of the null mutation of the PRLR gene by homologous 
recombination and gene targeting techniques. Black boxes represent exon 4, 5 and 6. NEO : 
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neomycin gene ; arrows indicate the position of primers used for PCR.  
B) PCR genotyping of immortalized brown adipocyte cell lines.  
C) Morphologic features of wild-type (WT), PRLR KO (KO) and rescued-PRLR 
(KO+PRLR) brown adipocytes on day 0 and day 6 of the differentiation program. All cell 
lines presented fibroblast-like morphology (day 0). Inset : immunodetection of the SV40 large 
T antigen in the nucleus of WT and PRLR KO brown adipocytes. WT, KO and KO+PRLR 
cell lines were cultured in the presence of 20 nM insulin and 2 nM T3 for 6 days. Light 
microscopic examination revealed the presence of numerous intracytoplasmic lipid droplets in 
the WT brown adipocyte cell line whereas PRLR KO brown adipocytes were unable to 
accumulate lipid droplets in their cytoplasm. Overexpression of PRLR in PRLR KO brown 
adipocytes (KO+PRLR) by stable transfection of a murine PRLR expression vector restores 
their ability to differentiate into mature brown adipocytes. 
D) RT-PCR analyses of PRLR, PPARγ2, UCP1 mRNA expression and 18S RNA used as 
internal control in WT, KO and rescued-PRLR (KO+PRLR) brown adipocytes. Note the 
reappearance of a strong PPARγ2 expression in rescued-PRLR differentiated brown 
adipocytes.  
 
Figure 4: IGF-2 is a target gene of PRL in brown adipose tissue 
A) qPCR analysis of IGF-2 mRNA expression of BAT from newborn mice, results are 
expressed as attomol of IGF-2/fmol of 18S, represent mean ± SE of 15-16 animals (*** p 
<0.001). 
B) Plasma IGF-2 levels. Values in WT (n=16) and in PRLR KO (n=21) animals represent the 
mean ± SE. (** p <0.01). 
C) IGF-2 mRNA is expressed as a function of brown adipocyte differentiation. IGF-2 mRNA 
expression was determined in immortalized WT, PRLR KO, and PRLR-rescued brown 
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adipocytes at day 0 or day 6 of the differentiation program. Results represent mean ± SE of 
three independent experiments performed in duplicate (*** p <0.001 vs WT at d0). 
D) Induction by PRL of IGF-2 mRNA expression in T37i cells. Differentiated T37i cells were 
incubated overnight with 10% horse serum known to lack prolactin and placental lactogens, 
and were stimulated or not by PRL (100 ng/ml) for 3 h. AG490 (100 μM) was added 15 min 
prior to PRL exposure. IGF-2 mRNA expression was expressed as mean ± SE of 12 
independent experiments (* p <0.05). 
E) STAT5 activation by PRL in T37i cells. Differentiated T37i cells, were stimulated with 
100 ng/ml PRL for 5 and 15 min. Protein lysates were subjected to immunoprecipitation with 
anti-STAT5 antibody. Samples were submitted to a SDS-PAGE and western blotting analysis 
using anti-phosphotyrosine STAT5 and STAT5 antibodies.  
F) Specific binding to a STAT response element located in the IGF-2 promoter region. The 
sequence of STAT-RE is underlined. Nuclear extracts from untreated (8 μg of proteins, lane 
1) and PRL-treated T37i cells (8 μg of proteins, lane 2 or 16 μg of proteins, lane 3) were 
analyzed for binding to a double-stranded STAT-RE oligonucleotide. Specific complexes 
were identified by competition experiments in which 100 ng unlabeled STAT-RE was added 
(lane 4). Free probe (lane 5). 
 
Figure 5: IGF-2 induces brown adipocyte proliferation and differentiation 
A) Undifferentiated (d2) and differentiated (d7) T37i cells were treated with 20 nM IGF-2 or 
20 nM insulin for 8 h. [3H]-thymidine (1 µCi per well) was then added to cells. Incorporation 
of [3H]-thymidine into DNA represents the mean ± SE (three independent experiments 
performed in quadruplicate) Statistical significance: * p<0.05 and ** p< 0.01.  
B) T37i cells were grown in medium supplemented with 10% dextran-coated charcoal serum 
in the absence (control) or in the presence of 20 nM IGF-2 for 6 days. A full differentiation 
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switch was observed with IGF-2. (Magnification X 20). Oil Red O staining was performed at 
d6 in the absence (base) or in the presence of 20 nM IGF-2, 20 nM insulin or 100 nM IGF-2. 
Oil Red O stained-cells were solubilized in 10% SDS and the OD520 measured. Results are 
mean ± SE of three independent experiments. Statistical significance: *p<0.05, **p<0.01 and 
***p<0.001, compared to untreated cells. 
Induction of PPARγ2 mRNA expression in T37i cells treated or not by 20 nM IGF-2 or  
20 nM insulin for 7 days. Quantitative real time PCR analysis of PPARγ2 mRNA expression 
was performed, results expressed as attomol of PPARγ2/fmol of 18S, represent mean ± SE of 
three independent experiments performed in duplicate expressed as fold induction vs 
undifferentiated cells (*p<0.05 and *** p <0.001). 
C) PRLR KO preadipocyte cells were grown in medium supplemented with 10% dextran-
coated charcoal serum without or with 20 nM IGF-2 for 6 days where the appearance of fully 
mature adipocyte foci were observed (Magnification x 20). 
 
Figure 6: Proposed model of regulation of brown adipocyte function by PRL/JAK2/STAT5 
/IGF-2 pathway 
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 Name     Accession number        Amplicon  Sense primer Antisense primer 
 
18S  X00686  66 bp CCCTGCCCTTTGTACACACC CGATCCGAGGGCCTCACTA 
PRLR BC005555 673 bp GAGAAAAACACCTATGAATGTC AGCAGTTCTTCAGACTTGCC 
PPARγ2  U09138 161 bp  GCATCAGGCTTCCACTATGGA AAGGCACTTCTGAAACCGACA 
SREBP1 BC056922  152 bp CGGCTGTTGTCTACCATAAGCTG CATAGATCTCTGCCAGTGTTGCC 
PGC-1α AF049330 162 bp CCCAGGCAGTAGATCCTCTTCAA  CCTTTCGTGCTCATAGGCTTCATA 
UCP1    BC012701 150 bp TCACCTTCCCGCTGGACACT GCAGGCAGACCGCTGTACAG  
β3AdR NM_013462 150 bp TGCGCACCTTAGGTCTCATTAT AAGGCGGAGTTGGCATAGC 
 
The abbreviations of the genes, their GENBANK or NCBI accession number, the size of the 
amplicon and 5’ to 3’nucleotide sequences of the sense and antisense primers are presented. 
 
Table 1. Primer sequences of genes analyzed in PCR, RT-PCR and Real Time PCR 
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